The Famotidine Injection, cataloged under National Stock Number 6505-01-646-7199, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-646-7199 |
| Primary Part Number | NDC63323-0738-20 |
| Item Name | Famotidine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 20.0 MILLILITERS |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| Active Medicament Medicinal Strength | 200.0 MILLIGRAMS FAMOTIDINE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0738-20 PRIMARY | Fresenius Kabi, Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM152334 | 5/1 Secondary reference Defense Medical Standardization Board |
| NDC63323-0738-20 | 5/9 Secondary reference Cencora, Inc. |
| 1349403 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-646-7199 is a Famotidine Injection, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-646-7199 has 1 manufacturer part number on file: NDC63323-0738-20 (Fresenius Kabi, Llc).
Key specifications for NDC63323-0738-20: Administration: INTRAVENOUS; Primary Container Content Quantity: 20.0 MILLILITERS; Primary Container Type: VIAL, MULTIPLE DOSE; Special Features: FAMOTIDINE INJ; 10MG/ML MULTIPLE DOSE VIAL; 20ML VIALS X 10 VIALS PER TRAY; FAMOTIDINE IS A COMPETITIVE INHIBITOR OF HISTAMINE H2 RECEPTORS; THE PRIMARY CLINICALLY IMPORTANT PHARMACOLOGIC ACTIVITY OF FAMOTIDINE IS INHIBITION OF GASTRIC SECRETION; STORE CONTAINER AT 2-8 DEGREES C; FOR INTRAVENOUS USE ONLY AFTER DILUTION; DILUTED FAMOTIDINE INJECTION SHOULD BE REFRIGERATED AND USED WITHIN 48 HOURS. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.